CN Patent

CN110507627A — 一种布地奈德的口服控释药物组合物

Assigned to Chongqing Medical and Pharmaceutical College · Expires 2019-11-29 · 6y expired

What this patent protects

本发明涉及一种布地奈德的口服控释药物组合物，其特征在于，包含：a)缓释片芯，所述缓释片芯含有布地奈德、所述布地奈德的药用盐或所述布地奈德的溶剂化物；b)至少一种两亲性基质；c)至少一种亲水性基质；所述布地奈德、所述布地奈德的药用盐或所述布地奈德的溶剂化物均匀分散于所述两亲性基质和/或所述亲水性基质中；在所述缓释片芯外部包一层含有耐酸材料的包衣。该组合物制备工艺简单、成本低，在小肠和结肠缓慢释放布地奈德，达到一日一次结肠靶向给药和局部治疗效果。

USPTO Abstract

本发明涉及一种布地奈德的口服控释药物组合物，其特征在于，包含：a)缓释片芯，所述缓释片芯含有布地奈德、所述布地奈德的药用盐或所述布地奈德的溶剂化物；b)至少一种两亲性基质；c)至少一种亲水性基质；所述布地奈德、所述布地奈德的药用盐或所述布地奈德的溶剂化物均匀分散于所述两亲性基质和/或所述亲水性基质中；在所述缓释片芯外部包一层含有耐酸材料的包衣。该组合物制备工艺简单、成本低，在小肠和结肠缓慢释放布地奈德，达到一日一次结肠靶向给药和局部治疗效果。

Drugs covered by this patent

Patent Metadata

Patent number
CN110507627A
Jurisdiction
CN
Classification
—
Expires
2019-11-29
Drug substance claim
No
Drug product claim
No
Assignee
Chongqing Medical and Pharmaceutical College
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.